Viewing Study NCT01415505


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-03-25 @ 7:27 AM
Study NCT ID: NCT01415505
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2011-08-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
Sponsor: Forest Laboratories
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NAC-MD-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators